Bictegravir has 3 known drug interactions based on U.S. FDA drug labeling data. Of these, 1 are contraindicated combinations that should be avoided entirely. Notable interactions include combinations with Rifabutin. Patients taking Bictegravir should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 3
- Contraindicated
- 1
Contraindicated (1)
- Bictegravir + Rifabutin— Rifabutin reduces bictegravir AUC by 38% and Cmin by 56%. Co-administration with Biktarvy is not recommended due to decr…